Report Detail
(Post-pandemic Era)-Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022
- RnM4477233 |
- 04 August, 2022 |
- Global |
- 110 Pages |
- XYZResearch |
- Medical Devices & Consumables
Summary
The global and Chinese economies were hit hard in 2020, and the global GDP grew by 5.9% in 2021. Although the global growth prospects improved and there was a V-shaped rebound, this does not mean that the economy has really recovered to the level before the epidemic. The vast majority of countries are still in the stage of recovery after heavy damage and are far from achieving real recovery.
2022 is a year of continuous recovery. Global supply chain disturbance, geopolitical tension, energy price fluctuation, local labor shortage and rising raw material prices will affect the resilience of economic recovery. The International Monetary Fund (IMF) predicts that the world economy will grow by 4.4% in 2022, of which the U.S. economy will grow by about 4%. Driven by China and India, Asia is expected to become the fastest growing region in the world in 2022. However, China's economic growth has slowed down. The 2022 government work report shows that the expected target of economic growth is set at about 5.5%.
According to research, China has set a growth rate of about 5.5%, which not only focuses on the speed of economic growth, but also anchors the quality of economic development. Scientific and technological innovation, economic and social digitization and green development will be the long-term goals of China's economic development. It is expected that in 2022, major economies such as the United States, Europe and China will introduce more favorable policies to drive the development of switching power supply industry.
Beijing Yanjing Bizhi Information Consulting Co., Ltd. （XYZResearch）released the 《(Post-pandemic Era)-Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022》, which aims to sort out the development status and trends of the Point-of-Care Infectious Disease Diagnostics & Testing industry at home and abroad, estimate the overall market scale of the Point-of-Care Infectious Disease Diagnostics & Testing industry and the market share of major countries, Point-of-Care Infectious Disease Diagnostics & Testing industry, and study and judge the downstream market demand of Point-of-Care Infectious Disease Diagnostics & Testing through systematic research, Analyze the competition pattern of Point-of-Care Infectious Disease Diagnostics & Testing, so as to help solve the pain points of various stakeholders in Point-of-Care Infectious Disease Diagnostics & Testing industry. This industry research report combines desktop research, qualitative interviews with insiders or experts and other methods to strive for the objectivity and integrity of conclusions and data.
Regional Segmentation (Value; Revenue, USD Million, 2018-2028) of Point-of-Care Infectious Disease Diagnostics & Testing Market by XYZResearch Include
USA
Europe
China
Japan
India
Korea
Southeast Asia
Competitive Analysis; Who are the Major Players in Point-of-Care Infectious Disease Diagnostics & Testing Market?
Abbott
Thermo Fisher Scientific Inc
Roche
Siemens Healthineers
BD & Company
Chembio Diagnostics Inc.
Trinity Biotech
Cardinal Health
Quest Diagnostics Inc.
Bio-Rad Labs Inc.
bioMérieux SA
Sight Diagnostics Ltd.
Gene POC
Trivitron Healthcare
OJ-Bio Ltd.
Ortho-Clinical Diagnostics
Major Type of Point-of-Care Infectious Disease Diagnostics & Testing Covered in XYZResearch report:
HIV POC
Clostridium difficile POC
HBV POC
Pneumonia or Streptococcus associated infections
Respiratory syncytial virus (RSV) POC
HPV POC
Influenza/Flu POC
Other Infectious Disease POC
Application Segments Covered in XYZResearch Market
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
For any other requirements, please feel free to contact us and we will provide you customized report.
Table of Contents
Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022
1. Research Scope
2. Market Overview
- 2.1 Product Introduction, Application, Picture
- 2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Value
- 2.2.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Revenue by Type
- 2.2.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Value (%)
- 2.3 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Production
- 2.3.1 Global Point-of-Care Infectious Disease Diagnostics & Testing Production by Type
- 2.3.2 Global Point-of-Care Infectious Disease Diagnostics & Testing Market by Production (%)
3. The Major Driver of Point-of-Care Infectious Disease Diagnostics & Testing Industry
- 3.1 Historical & Forecast Global Point-of-Care Infectious Disease Diagnostics & Testing Demand
- 3.2 Largest Application for Point-of-Care Infectious Disease Diagnostics & Testing (2018-2028)
- 3.3 The Major Downstream Company in China Market 2022
4. Global and Regional Point-of-Care Infectious Disease Diagnostics & Testing Market
- 4.1 Regional Market Size in Terms of Production & Demand (2022)
- 4.2 Regional Market Share in Terms of Revenue (2018-2022)
- 4.3 Concentration Ratio (CR5& CR10) of Point-of-Care Infectious Disease Diagnostics & Testing Market
- 4.4 Mergers & Acquisitions, Expansion Plans
5. US Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)
- 5.1 Current and Estimated Production Breakdown by Type
- 5.2 Current and Estimated Demand Breakdown by Type
- 5.3 Current and Estimated Demand Breakdown by Application
- 5.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 5.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
6. Europe Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)
- 6.1 Current and Estimated Production Breakdown by Type
- 6.2 Current and Estimated Demand Breakdown by Type
- 6.3 Current and Estimated Demand Breakdown by Application
- 6.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 6.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
7. China Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)
- 7.1 Current and Estimated Production Breakdown by Type
- 7.2 Current and Estimated Demand Breakdown by Type
- 7.3 Current and Estimated Demand Breakdown by Application
- 7.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 7.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
8. Japan Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)
- 8.1 Current and Estimated Production Breakdown by Type
- 8.2 Current and Estimated Demand Breakdown by Type
- 8.3 Current and Estimated Demand Breakdown by Application
- 8.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 8.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
9. India Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)
- 9.1 Current and Estimated Production Breakdown by Type
- 9.2 Current and Estimated Demand Breakdown by Type
- 9.3 Current and Estimated Demand Breakdown by Application
- 9.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 9.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
10. Korea Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)
- 10.1 Current and Estimated Production Breakdown by Type
- 10.2 Current and Estimated Demand Breakdown by Type
- 10.3 Current and Estimated Demand Breakdown by Application
- 10.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 10.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
11. Southeast Asia Point-of-Care Infectious Disease Diagnostics & Testing Production, Demand (2018-2028)
- 11.1 Current and Estimated Production Breakdown by Type
- 11.2 Current and Estimated Demand Breakdown by Type
- 11.3 Current and Estimated Demand Breakdown by Application
- 11.4 Current and Estimated Revenue Breakdown by Type (2018-2028)
- 11.5 Current and Estimated Revenue Breakdown by Application (2018-2028)
12. Global Point-of-Care Infectious Disease Diagnostics & Testing Average Price Trend
- 12.1 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in US (2018-2022)
- 12.2 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Europe (2018-2022)
- 12.3 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in China (2018-2022)
- 12.4 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Japan (2018-2022)
- 12.5 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in India (2018-2022)
- 12.6 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Korea (2018-2022)
- 12.7 Market Price for Each Type of Point-of-Care Infectious Disease Diagnostics & Testing in Southeast Asia (2018-2022)
13. Industrial Chain (Impact of COVID-19)
- 13.1 Point-of-Care Infectious Disease Diagnostics & Testing Industrial Chain Analysis
- 13.2 Downstream
- 13.3 Impact of COVID-19
- 13.4 Post-pandemic Era
- 13.5 Technology Trends of Point-of-Care Infectious Disease Diagnostics & Testing
14. Point-of-Care Infectious Disease Diagnostics & Testing Competitive Landscape
- 14.1 Abbott
- 14.1.1 Abbott Company Profiles
- 14.1.2 Abbott Product Introduction
- 14.1.3 Abbott Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.1.4 Strategic initiatives
- 14.2 Thermo Fisher Scientific Inc
- 14.2.1 Thermo Fisher Scientific Inc Company Profiles
- 14.2.2 Thermo Fisher Scientific Inc Product Introduction
- 14.2.3 Thermo Fisher Scientific Inc Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.2.4 Strategic initiatives
- 14.3 Roche
- 14.3.1 Roche Company Profiles
- 14.3.2 Roche Product Introduction
- 14.3.3 Roche Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.3.4 Strategic initiatives
- 14.4 Siemens Healthineers
- 14.4.1 Siemens Healthineers Company Profiles
- 14.4.2 Siemens Healthineers Product Introduction
- 14.4.3 Siemens Healthineers Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.4.4 Strategic initiatives
- 14.5 BD & Company
- 14.5.1 BD & Company Company Profiles
- 14.5.2 BD & Company Product Introduction
- 14.5.3 BD & Company Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.5.4 Strategic initiatives
- 14.6 Chembio Diagnostics Inc.
- 14.6.1 Chembio Diagnostics Inc. Company Profiles
- 14.6.2 Chembio Diagnostics Inc. Product Introduction
- 14.6.3 Chembio Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.6.4 Strategic initiatives
- 14.7 Trinity Biotech
- 14.7.1 Trinity Biotech Company Profiles
- 14.7.2 Trinity Biotech Product Introduction
- 14.7.3 Trinity Biotech Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.7.4 Strategic initiatives
- 14.8 Cardinal Health
- 14.8.1 Cardinal Health Company Profiles
- 14.8.2 Cardinal Health Product Introduction
- 14.8.3 Cardinal Health Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.8.4 Strategic initiatives
- 14.9 Quest Diagnostics Inc.
- 14.9.1 Quest Diagnostics Inc. Company Profiles
- 14.9.2 Quest Diagnostics Inc. Product Introduction
- 14.9.3 Quest Diagnostics Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.9.4 Strategic initiatives
- 14.10 Bio-Rad Labs Inc.
- 14.10.1 Bio-Rad Labs Inc. Company Profiles
- 14.10.2 Bio-Rad Labs Inc. Product Introduction
- 14.10.3 Bio-Rad Labs Inc. Point-of-Care Infectious Disease Diagnostics & Testing Sales, Revenue (2018-2022)
- 14.10.4 Strategic initiatives
- 14.11 bioMérieux SA
- 14.12 Sight Diagnostics Ltd.
- 14.13 Gene POC
- 14.14 Trivitron Healthcare
- 14.15 OJ-Bio Ltd.
- 14.16 Ortho-Clinical Diagnostics
15. Conclusion
16. Methodology and Data Source
Summary:
Get latest Market Research Reports on Point-of-Care Infectious Disease Diagnostics & Testing. Industry analysis & Market Report on Point-of-Care Infectious Disease Diagnostics & Testing is a syndicated market report, published as (Post-pandemic Era)-Global Point-of-Care Infectious Disease Diagnostics & Testing Market Segment Research Report 2022. It is complete Research Study and Industry Analysis of Point-of-Care Infectious Disease Diagnostics & Testing market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
